Geneplus-Beijing Co. Ltd. Funding: $333M Raised, Series D
Geneplus-Beijing Co. Ltd. is based in Beijing, China. It has raised $333M in total funding. Latest round: Series D.
Geneplus-Beijing Co. Ltd. funding overview
Geneplus-Beijing Co. Ltd. is based in Beijing, China. Geneplus-Beijing Co. Ltd. has raised $333M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in December 2023. The round record for Geneplus-Beijing Co. Ltd. runs through 2023; nothing later has been disclosed. Investors on record include BGI, CCB International, Baidu Ventures, AliHealth, GGV Capital. 5 distinct backers are named across the disclosed rounds.
Geneplus-Beijing Co. Ltd. at a glance
Total raised
$333M
Latest round
Series D
Latest round date
December 2023
Headquarters
Beijing, China
Notable investors
BGI, CCB International, Baidu Ventures, AliHealth, GGV Capital
Frequently asked about Geneplus-Beijing Co. Ltd. funding
How much has Geneplus-Beijing Co. Ltd. raised?
Geneplus-Beijing Co. Ltd. has raised $333M in total disclosed funding across the rounds on record.
Who has invested in Geneplus-Beijing Co. Ltd.?
BGI, CCB International, Baidu Ventures, AliHealth, GGV Capital are named among the investors backing Geneplus-Beijing Co. Ltd..
What was the latest Geneplus-Beijing Co. Ltd. funding round?
The most recent disclosed round is a Series D, announced in December 2023.
Where is Geneplus-Beijing Co. Ltd. based?
Geneplus-Beijing Co. Ltd. is based in Beijing, China.
When did Geneplus-Beijing Co. Ltd. last raise?
The last disclosed Geneplus-Beijing Co. Ltd. round closed in December 2023 at Series D.
Totals shown for Geneplus-Beijing Co. Ltd. aggregate every disclosed round on file. To see how that compares, browse the companies in Beijing and the investors behind them below.
Companies related to Geneplus-Beijing Co. Ltd. (18)
